Assisted by our pharmaceutical and medical expertise, we are offering an excellent quality Clindanext-150 that works by stopping the growth of bacteria. The offered products are utilized to treat certain types of bacterial infections, including infections of the bones, joints, lungs, skin, blood, female reproductive organs, and internal organs. In line with international standard, we are offering this Clindanext-150 in varied packaging options. Effectiveness, accurate composition and long shelf life are some of the salient features of our medicine.
Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
"We are inviting inquiries only from South America, Africa, Middle East, Cih, South East Asia."
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD.
1302, Rupa Solitaire, Millenium Business Park (MBP), Next to Hotel Ramada, Mahape, Navi Mumbai - 400710, Maharashtra, India